AARTI DRUGS
|
|
BOM : 524348     NSE : AARTIDRUGS     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Average |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward Pledged Shares : None or < 25% |
Sep 25,2023 |
Price(EOD): βΉ 552.50
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: βΉ 5,077.48 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
AARTI DRUGS | -6.8% | -1.4% | 20% |
SUN PHARMACEUTICAL INDUSTRIES | -2.1% | 0.6% | 23.6% |
DIVIS LABORATORIES | -1.4% | 2% | 2% |
CIPLA | -5% | -3.3% | 8.7% |
DR REDDYS LABORATORIES | -5% | -7.9% | 30.8% |
TORRENT PHARMACEUTICALS | -2% | -5.8% | 22.5% |
ABBOTT INDIA | -2.8% | -2.2% | 24.5% |
ZYDUS LIFESCIENCES | -6.4% | -6% | 60.7% |
ALKEM LABORATORIES | -2.9% | -4.3% | 6.8% |
FUNDAMENTAL ANALYSIS OF AARTI DRUGS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF AARTI DRUGS
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
28.29
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 179.56 Cr
[Latest Qtr - Jun2023 - Consolidated Results ] 4.26
P/B Calculated based on Book Value of Rs 1,192.44 Cr
[Latest Year - Mar2023 - Consolidated Results ] 1.84
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 2,755.20 Cr
[Latest Qtr - Jun2023 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
160% 113% 233% |
SHARE PRICE MOMENTUM OF AARTI DRUGS
AARTI DRUGS vs SENSEX
DEBT OF AARTI DRUGS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.53 0.38 0.59 0.5 |
0.52 0.38 0.58 0.49 |
[Last Annual Data : Mar2023]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF AARTI DRUGS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Jun2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF AARTI DRUGS
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-10.95% -10.12% -13.31% -14.61% |
6.29% 25.22% 32.27% 37.92% |
QtrlyTrend |
0 | |
Latest Qtr: Jun2023 | ||
Quarterly Result Analysis → |
AARTI DRUGS related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE MIDSMALLCAP | -1.6% | 3.3% | 26.5% |
S&P BSE 400 MIDSMALLCAP | -1.7% | 3% | 25.6% |
S&P BSE 250 SMALLCAP | -1.9% | 3.5% | 28.3% |
S&P BSE SMALL CAP | -1.9% | 2.9% | 27.3% |
S&P BSE ALLCAP | -2.2% | 1.9% | 13.3% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MID SMALL400 | -1.4% | 3.8% | 26.9% |
NIFTY500 MULTICAP 50:25:25 | -2% | 2.6% | 17.9% |
NIFTY SMALLCAP250 | -2.1% | 4% | 28.2% |
NIFTY 500 | -2.2% | 1.9% | 12.9% |
You may also like the below Video Courses
FAQ about AARTI DRUGS
Is AARTI DRUGS good for long term investment?
As on Sep 25,2023, the Fundamentals of AARTI DRUGS look Strong and hence it may be good for long term investment! See Financial Performance of AARTI DRUGS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is AARTI DRUGS UnderValued or OverValued?
As on Sep 25,2023, AARTI DRUGS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of AARTI DRUGS ?
As on Sep 25,2023, the Intrinsic Value of AARTI DRUGS is Rs. 212.23 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 212.23
Fair Value [Median EV / Sales Model] : Rs. 259.29
Fair Value [Median Price / Sales Model] : Rs. 165.68
Estimated Median Fair Value of AARTI DRUGS : Rs. 212.23
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is AARTI DRUGS trading at a Premium or Discount?
As on Sep 25,2023, AARTI DRUGS is trading at a Premium of 160% based on the estimates of Median Intrinsic Value!